Alphamab Oncology has announced the grant of award shares under its Restricted Share Award Scheme, as disclosed in a recent filing with The Stock Exchange of Hong Kong Limited. The company aims to recognize and reward the contributions of its Award Directors, providing them with shares as part of their compensation. The shares granted to the Award Directors do not have specific performance targets, aligning with the company's remuneration policy. This initiative is part of the company's efforts to closely align the interests of its shareholders, the company, and its directors. The announcement, made by Chairman Dr. Xu Ting, highlights the company's focus on its continual operation and long-term growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.